Esperion Therapeutics Inc’s recent filing unveils that its Officer Warren Eric acquired Company’s shares for reported $5426.0 on Dec 17 ’24. In the deal valued at $2.43 per share,2,234 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Koenig Sheldon L. bought 12,447 shares, generating $30,698 in total proceeds.
Before that, Halladay Benjamin bought 3,245 shares. Esperion Therapeutics Inc shares valued at $7,865 were divested by the Officer at a price of $2.42 per share.
Cantor Fitzgerald initiated its Esperion Therapeutics Inc [ESPR] rating to an Overweight in a research note published on December 17, 2024; the price target was $8. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in mid June from “a Neutral” to “an Underperform”. BofA Securities also remained covering ESPR and has decreased its forecast on January 03, 2024 with a “Neutral” recommendation from previously “Buy” rating.
Price Performance Review of ESPR
On Tuesday, Esperion Therapeutics Inc [NASDAQ:ESPR] saw its stock jump 5.58% to $2.46. Over the last five days, the stock has lost -19.08%. Esperion Therapeutics Inc shares have fallen nearly -17.73% since the year began. Nevertheless, the stocks have risen 35.16% over the past one year. While a 52-week high of $3.94 was reached on 12/09/24, a 52-week low of $1.58 was recorded on 10/02/24. SMA at 50 days reached $2.39, while 200 days put it at $2.24.
Levels Of Support And Resistance For ESPR Stock
The 24-hour chart illustrates a support level at 2.36, which if violated will result in even more drops to 2.26. On the upside, there is a resistance level at 2.55. A further resistance level may holdings at 2.64. The Relative Strength Index (RSI) on the 14-day chart is 46.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.48%. Stochastics %K at 24.12% indicates the stock is a holding.
How much short interest is there in Esperion Therapeutics Inc?
A steep rise in short interest was recorded in Esperion Therapeutics Inc stocks on 2024-11-29, dropping by -2.97 million shares to a total of 30.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 33.46 million shares. There was a decline of -9.74%, which implies that there is a negative sentiment for the stock.
